APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Medicine & Radiopharmaceuticals

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

Selected research

Industry Growth & Trends

Global Nuclear Medicine & Radiopharmaceuticals Industry Growth and Trends Forecast to 2032

1 January 202691 pages

Choose your research edition.

Industry ResearchNuclear Medicine & Radiopharmaceuticals Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Medicine & Radiopharmaceuticals Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Nuclear Medicine & Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Medicine & Radiopharmaceuticals Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Medicine & Radiopharmaceuticals Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Nuclear Medicine & Radiopharmaceuticals market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nuclear Medicine & Radiopharmaceuticals market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nuclear Medicine & Radiopharmaceuticals market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nuclear Medicine & Radiopharmaceuticals.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nuclear Medicine & Radiopharmaceuticals market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nuclear Medicine & Radiopharmaceuticals Market by Company

China Isotope & Radiation

Dongcheng

Jaco

Ciaeriar

Advanced Molecular-imaging Solution

Shanghai Atom Kexing

Nuclear Medicine & Radiopharmaceuticals Segment by Type

Diagnostic

Therapeutic

Nuclear Medicine & Radiopharmaceuticals Segment by Application

Oncology

Thyroid

Cardiology

Others

Nuclear Medicine & Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine & Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine & Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine & Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nuclear Medicine & Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nuclear Medicine & Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Diagnostic Table 2. Major Company of Therapeutic Table 3. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Type (2021-2026) Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 7. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Type (2021-2026) Table 8. Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2021-2026) & (US$/Unit) Table 9. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 10. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Type (2027-2032) Table 11. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2027-2032) & (US$ Million) Table 12. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Type (2027-2032) Table 13. Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2027-2032) & (US$/Unit) Table 14. North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 15. North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 17. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 21. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 24. Nuclear Medicine & Radiopharmaceuticals Industry Trends Table 25. Nuclear Medicine & Radiopharmaceuticals Industry Drivers Table 26. Nuclear Medicine & Radiopharmaceuticals Industry Opportunities and Challenges Table 27. Nuclear Medicine & Radiopharmaceuticals Industry Restraints Table 28. Global Nuclear Medicine & Radiopharmaceuticals Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2021-2026) Table 30. Global Nuclear Medicine & Radiopharmaceuticals Sales by Company (2021-2026) & (K Units) Table 31. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Company (2021-2026) Table 32. Global Nuclear Medicine & Radiopharmaceuticals Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Nuclear Medicine & Radiopharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Nuclear Medicine & Radiopharmaceuticals Major Company Production Sites and Headquarters Table 35. Global Nuclear Medicine & Radiopharmaceuticals Company, Product Type & Application Table 36. Global Nuclear Medicine & Radiopharmaceuticals Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Nuclear Medicine & Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Nuclear Medicine & Radiopharmaceuticals Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2021-2026) & (K Units) Table 41. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Region (2021-2026) Table 42. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2021-2026) & (US$ Million) Table 43. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Region (2021-2026) Table 44. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2027-2032) & (K Units) Table 46. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Region (2027-2032) Table 47. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2027-2032) & (US$ Million) Table 48. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Region (2027-2032) Table 49. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 52. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Application (2021-2026) Table 53. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 54. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Application (2021-2026) Table 55. Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2021-2026) & (US$/Unit) Table 56. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 57. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Application (2027-2032) Table 58. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2027-2032) & (US$ Million) Table 59. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Application (2027-2032) Table 60. Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2027-2032) & (US$/Unit) Table 61. North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 62. North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 64. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 68. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 71. China Isotope & Radiation Company Information Table 72. China Isotope & Radiation Business Overview Table 73. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolio Table 75. China Isotope & Radiation Recent Development Table 76. Dongcheng Company Information Table 77. Dongcheng Business Overview Table 78. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolio Table 80. Dongcheng Recent Development Table 81. Jaco Company Information Table 82. Jaco Business Overview Table 83. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolio Table 85. Jaco Recent Development Table 86. Ciaeriar Company Information Table 87. Ciaeriar Business Overview Table 88. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolio Table 90. Ciaeriar Recent Development Table 91. Advanced Molecular-imaging Solution Company Information Table 92. Advanced Molecular-imaging Solution Business Overview Table 93. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolio Table 95. Advanced Molecular-imaging Solution Recent Development Table 96. Shanghai Atom Kexing Company Information Table 97. Shanghai Atom Kexing Business Overview Table 98. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolio Table 100. Shanghai Atom Kexing Recent Development Table 101. North America Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 103. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 104. North America Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 106. North America Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Nuclear Medicine & Radiopharmaceuticals Market Share by Country (2021-2026) Table 109. North America Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Nuclear Medicine & Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 111. Europe Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 113. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 114. Europe Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Nuclear Medicine & Radiopharmaceuticals Market Share by Country (2021-2026) Table 119. Europe Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Nuclear Medicine & Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Share by Country (2021-2026) Table 129. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 131. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 133. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 134. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Nuclear Medicine & Radiopharmaceuticals Market Share by Country (2021-2026) Table 139. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Nuclear Medicine & Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Share by Country (2021-2026) Table 149. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Nuclear Medicine & Radiopharmaceuticals Distributors List Table 154. Nuclear Medicine & Radiopharmaceuticals Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Nuclear Medicine & Radiopharmaceuticals Image Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 4. Global Nuclear Medicine & Radiopharmaceuticals Sales (2021-2032) & (K Units) Figure 5. Diagnostic Image Figure 6. Global Diagnostic Sales YoY Growth (2021-2032) & (K Units) Figure 7. Therapeutic Image Figure 8. Global Therapeutic Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Nuclear Medicine & Radiopharmaceuticals Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Nuclear Medicine & Radiopharmaceuticals Market Share by Type 2025 VS 2032 Figure 11. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 12. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 13. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 14. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 17. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Nuclear Medicine & Radiopharmaceuticals Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Oncology Image Figure 24. Global Oncology Sales YoY Growth (2021-2032) & (K Units) Figure 25. Thyroid Image Figure 26. Global Thyroid Sales YoY Growth (2021-2032) & (K Units) Figure 27. Cardiology Image Figure 28. Global Cardiology Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Nuclear Medicine & Radiopharmaceuticals Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Nuclear Medicine & Radiopharmaceuticals Market Share by Application 2025 VS 2032 Figure 33. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 34. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 35. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 36. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 39. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 43. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Nuclear Medicine & Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Nuclear Medicine & Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Nuclear Medicine & Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Nuclear Medicine & Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Nuclear Medicine & Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Nuclear Medicine & Radiopharmaceuticals Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Nuclear Medicine & Radiopharmaceuticals Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic
  • Therapeutic
Applications
  • Oncology
  • Thyroid
  • Cardiology
  • Others
Companies covered
  • China Isotope & Radiation
  • Dongcheng
  • Jaco
  • Ciaeriar
  • Advanced Molecular-imaging Solution
  • Shanghai Atom Kexing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nuclear Medicine & Radiopharmaceuticals Market by Type
  6. 1.3.1 Diagnostic
  7. 1.3.2 Therapeutic
  8. 1.4 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type
  9. 1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Nuclear Medicine & Radiopharmaceuticals Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nuclear Medicine & Radiopharmaceuticals Industry Trends
  2. 2.2 Nuclear Medicine & Radiopharmaceuticals Industry Drivers
  3. 2.3 Nuclear Medicine & Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Nuclear Medicine & Radiopharmaceuticals Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nuclear Medicine & Radiopharmaceuticals Revenue (2021-2026)
  2. 3.2 Global Top Players by Nuclear Medicine & Radiopharmaceuticals Sales (2021-2026)
  3. 3.3 Global Top Players by Nuclear Medicine & Radiopharmaceuticals Price (2021-2026)
  4. 3.4 Global Nuclear Medicine & Radiopharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nuclear Medicine & Radiopharmaceuticals Major Company Production Sites & Headquarters
  6. 3.6 Global Nuclear Medicine & Radiopharmaceuticals Company, Product Type & Application
  7. 3.7 Global Nuclear Medicine & Radiopharmaceuticals Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nuclear Medicine & Radiopharmaceuticals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nuclear Medicine & Radiopharmaceuticals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nuclear Medicine & Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 Nuclear Medicine & Radiopharmaceuticals Regional Status and Outlook
  1. 4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Size by Region
  3. 4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nuclear Medicine & Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nuclear Medicine & Radiopharmaceuticals Forecasted Market Size by Region
  7. 4.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nuclear Medicine & Radiopharmaceuticals Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nuclear Medicine & Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nuclear Medicine & Radiopharmaceuticals by Application
  1. 5.1 Nuclear Medicine & Radiopharmaceuticals Market by Application
  2. 5.1.1 Oncology
  3. 5.1.2 Thyroid
  4. 5.1.3 Cardiology
  5. 5.1.4 Others
  6. 5.2 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application
  7. 5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 China Isotope & Radiation
  2. 6.1.1 China Isotope & Radiation Company Information
  3. 6.1.2 China Isotope & Radiation Business Overview
  4. 6.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolio
  6. 6.1.5 China Isotope & Radiation Recent Developments
  7. 6.2 Dongcheng
  8. 6.2.1 Dongcheng Company Information
  9. 6.2.2 Dongcheng Business Overview
  10. 6.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolio
  12. 6.2.5 Dongcheng Recent Developments
  13. 6.3 Jaco
  14. 6.3.1 Jaco Company Information
  15. 6.3.2 Jaco Business Overview
  16. 6.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolio
  18. 6.3.5 Jaco Recent Developments
  19. 6.4 Ciaeriar
  20. 6.4.1 Ciaeriar Company Information
  21. 6.4.2 Ciaeriar Business Overview
  22. 6.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolio
  24. 6.4.5 Ciaeriar Recent Developments
  25. 6.5 Advanced Molecular-imaging Solution
  26. 6.5.1 Advanced Molecular-imaging Solution Company Information
  27. 6.5.2 Advanced Molecular-imaging Solution Business Overview
  28. 6.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolio
  30. 6.5.5 Advanced Molecular-imaging Solution Recent Developments
  31. 6.6 Shanghai Atom Kexing
  32. 6.6.1 Shanghai Atom Kexing Company Information
  33. 6.6.2 Shanghai Atom Kexing Business Overview
  34. 6.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolio
  36. 6.6.5 Shanghai Atom Kexing Recent Developments
7 North America by Country
  1. 7.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country
  2. 7.1.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026)
  4. 7.1.3 North America Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
  6. 7.2.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 7.2.3 North America Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country
  2. 8.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026)
  4. 8.1.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country
  6. 8.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Country
  2. 9.1.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Country
  6. 9.2.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nuclear Medicine & Radiopharmaceuticals Sales by Country
  2. 10.1.1 South America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026)
  4. 10.1.3 South America Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
  6. 10.2.1 South America Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 10.2.3 South America Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country
  2. 11.1.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country
  6. 11.2.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nuclear Medicine & Radiopharmaceuticals Value Chain Analysis
  2. 12.1.1 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nuclear Medicine & Radiopharmaceuticals Production Mode & Process
  7. 12.2 Nuclear Medicine & Radiopharmaceuticals Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nuclear Medicine & Radiopharmaceuticals Distributors
  10. 12.2.3 Nuclear Medicine & Radiopharmaceuticals Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst